Balyasny Asset Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $5.43 Million - $6.4 Million	-121,723 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $2 Million - $2.48 Million	-43,571 Reduced 26.36%	121,723 $6.2 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $7.24 Million - $9.22 Million	165,294 New	165,294 $9.22 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $1.11 Million - $1.48 Million	-28,633 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $1.05 Million - $1.94 Million	28,633 New	28,633 $1.15 Million

5.33M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $15.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.